Jameshebrew · Newsroom

The peptides and macrocycle drug discovery services market is estimated to be worth USD 1.5 billion in 2030, predicts Roots Analysis
Given the recent developments in healthcare, supporting safety and efficacy of peptide and affiliated macrocycle drugs, the industry is presently witnessing an increase in discovery and development initiatives related to such therapeutic modalities.

September 20, 2021

The RNAi therapeutics market is anticipated to grow at an annualized rate of more than 45%, till 2030, claims Roots Analysis
The recent approval of first RNAi therapeutic, ONPATTROTM, has caused a surge in interest of the industry / non-industry players in upcoming field of pharmacological research

September 20, 2021

The biopharmaceutical CROs market is projected to be worth USD 67 billion by 2030, claims Roots Analysis
Over past few years, pharmaceutical companies have outsourced various aspects of their R&D and clinical research processes to specialty contract research service providers, in order to remain competitive, flexible, and profitable in the industry

September 16, 2021

The TIL-based therapies market is projected to be worth over USD 4.3 billion, by 2030, claims Roots Analysis
Driven by the potential to confer sustained therapeutic effects and thereby, facilitate prolonged periods of remission, TIL-based therapies have received significant financial support, and promising leads are poised to soon achieve blockbuster status

September 16, 2021

The polycystic ovary syndrome market, is anticipated to be worth USD 5 billion by 2031, growing at an annualized rate of 4%, claims Roots Analysis
polycystic ovary syndrome affects 1 in 10 women of childbearing age. The exact cause of the condition is unknown; however, obesity, high levels of inflammation and insulin resistance are the common risk factors

September 16, 2021

Human Microbiome Market, 2019-2030 by Roots Analysis
Over the years, extensive R&D efforts have established the basis for a wide range of microbiome-based therapeutic and diagnostic products, which may cause a paradigm shift in the way healthcare is delivered in the foreseen future

September 2, 2021

Patient Recruitment and Retention Services Marker, 2019-2030 by Roots Analysis
A steadily increasing demand for participants in clinical research studies, coupled to the complexities associated with patient enrolment, have prompted drug / therapy developers to outsource this process to specialty service providers

September 2, 2021

Liquid Biopsy and Other Non-Invasive Cancer Diagnostics Market By Rootsanalysis
Liquid biopsies have emerged as a versatile diagnostic solution, especially for cases when conventional (invasive) diagnostic tests are inconclusive or when the clinical condition is related to an organ that is not amenable to biopsy access

August 31, 2021

Drug Repurposing Service Providers Market, 2020-2030 By Roots Analysis
Drug repurposing enables drug developers to optimize on past efforts and expenditure, thereby, offering a viable life cycle management strategy for marketed products and opportunities to re-evaluate failed / shelved drug development programs

August 31, 2021

Elastomeric Closure Components Market For Vials, Cartridges and Syringes by Roots Analysis
Driven by the growing complexity of modern pharmacological interventions, industry stakeholders have developed container-closures systems using more versatile materials; in this context, elastomers have demonstrated significant potential

August 26, 2021

Manufacturing Market Continuous by Roots Analysis
Recent advances in the manufacturing technologies have prompted pharmaceutical companies to consider shifting from the traditional multi-step, batch manufacturing processes to faster, and relatively more efficient continuous manufacturing

August 26, 2021

The endocannabinoid system targeted therapeutics market is projected to be over USD 5 billion by 2030
So far, more than 100 different types of cannabinoids have been identified and there is a growing body of evidence supporting the benefits of this class of compounds in offering symptomatic relief for a wide variety of chronic health conditions

August 17, 2021

The global preventive vaccines market is projected to be worth USD 94 billion by 2030, growing at a CAGR of 10.7%, claims Roots Analysis
Although vaccines were solely responsible for the global eradication of smallpox (1980) and polio (2015), several vaccine-preventable diseases, such as measles and mumps, are still a threat; COVID-19 has been recently added to the list

August 17, 2021

The biopharmaceutical contract biomanufacturing market is projected to be worth USD 32.4 billion by 2030
Owing to the complexities associated with the production of biologics, biopharmaceutical developers are likely to continue relying on contract service providers for various aspects of their respective product development programs

August 13, 2021

The CAR-T therapies market is characterized by a healthy pipeline of promising therapies, and is projected to be worth around USD 14 Billion in 2030
Given the success of approved CAR-T cell therapies, such as KYMRIAH®, YESCARTA®, TECARTUS® and BREYANZI®, this upcoming class of biologics are anticipated to carve out a significant share of the multi-billion dollar cancer immunotherapy market

August 13, 2021

The non-invasive cancer diagnostics market is estimated to be worth around USD 20.1 billion by 2030, predicts Roots Analysis
Liquid biopsies have emerged as a versatile diagnostic solution, especially for cases when conventional (invasive) diagnostic tests are inconclusive or when the clinical condition is related to an organ that is not amenable to biopsy access

August 9, 2021

The drug repurposing service providers market is estimated to be worth USD 1.2 billion in 2030, predicts Roots Analysis
Drug repurposing enables drug developers to optimize on past efforts and expenditure, thereby, offering a viable life cycle management strategy for marketed products and opportunities to re-evaluate failed / shelved drug development programs

August 9, 2021

The gene therapy market is projected to be worth USD 14.6 billion in 2030, growing at a CAGR of 30%, over the next decade, claims Roots Analysis
Driven by the potential to treat the root cause of diseases, including rare clinical conditions and those that were previously deemed incurable, the gene therapies pipeline is growing.

August 3, 2021

Human Microbiome-based Products Market is projected to be worth USD 4 Billion by 2030, claims Roots Analysis
Over the years, extensive R&D efforts have established the basis for a wide range of microbiome-based therapeutic and diagnostic products, which may cause a paradigm shift in the way healthcare is delivered in the foreseen future

August 3, 2021

The fragment-based drug discovery market is estimated to be worth around USD 1.6 billion by 2030, predicts Roots Analysis
Screening small molecule fragments has made it possible to identify pharmacological leads against otherwise hard to target hotspots on biomolecules, such as allosteric sites, rendering this approach a valuable alternative method of drug discovery

July 29, 2021

Encapsulated cell therapies and encapsulation technologies are being evaluated across different phases of development, claims Roots Analysis
Extensive research on cell encapsulation strategies has enabled the development of a variety of technologies capable of immobilizing / enclosing therapeutic entities within biocompatible matrices / carriers.

July 29, 2021

The novel vaccine delivery devices market is estimated to be worth USD 1.5 billion in 2030, predicts Roots Analysis
Owning to a variety of relevant reasons, which include trypanophobia and dependence on the cold chain, there is an evident demand for innovative and user-friendly vaccine delivery systems that are also safe and efficient

July 26, 2021

The “Encapsulated Cell Therapies and Encapsulation Technologies Market” report
An in-depth analysis of the patents that have been published related to cell encapsulation technologies.

July 26, 2021